Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · IEX Real-Time Price · USD
29.03
-0.16 (-0.55%)
Apr 18, 2024, 4:00 PM EDT - Market closed

HRMY Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Cash & Equivalents
311.66243.78234.31228.6324.4683.52
Short-Term Investments
41.879.330000
Cash & Cash Equivalents
353.46323.12234.31228.6324.4683.52
Cash Growth
9.39%37.90%2.48%834.83%-70.72%-
Receivables
74.1454.7434.8422.184.260
Inventory
5.364.34.433.821.090
Other Current Assets
18.1118.1310.868.261.73.16
Total Current Assets
451.07400.29284.44262.8931.586.68
Property, Plant & Equipment
0.370.570.820.941.331.58
Long-Term Investments
72.4423.320.750.750.750.5
Goodwill and Intangibles
137.11160.95143.92162.3472.190
Other Long-Term Assets
150.4688.743.520.150.940.52
Total Long-Term Assets
360.38273.59149164.1875.212.6
Total Assets
811.45673.87433.44427.07106.789.28
Accounts Payable
17.733.7912.566.361.46
Current Debt
1522000
Other Current Liabilities
131.0573.150.77131.9813.535.77
Total Current Liabilities
163.7878.8853.78134.5419.897.23
Long-Term Debt
178.57189.65189.98194.2597.950
Other Long-Term Liabilities
2.112.53.181.110.450.52
Total Long-Term Liabilities
180.68192.15193.16195.3698.40.52
Total Liabilities
344.46271.03246.94329.89118.297.75
Total Debt
193.57191.65191.98194.2597.950
Debt Growth
1.00%-0.18%-1.17%98.32%--
Retained Earnings
-143.28-272.13-453.6-488.2-422.86-242.67
Comprehensive Income
0-0.150000
Shareholders' Equity
466.99402.84186.5197.18-422.86-242.67
Net Cash / Debt
159.89131.4742.3334.38-73.4983.52
Net Cash / Debt Growth
21.62%210.62%23.11%---
Net Cash Per Share
2.652.150.711.33-9.459.43
Working Capital
287.29321.4230.66128.3511.6179.45
Book Value Per Share
7.856.813.243.77-54.37-27.40
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).